Home > Insider Trading > Filing (0001209191-17-024862)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1610618	Cidara Therapeutics Inc.	CDTX	Biological Products, (No Disgnostic Substances) (2836)	461537286

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1638943	Kevin Forrest	6310 Nancy Ridge Drive Suite 101 San Diego CA 92121	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-03-31	12,500	$7.75	72,354	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Acquisiton	2017-03-31	60,000	$0.00	60,000	$7.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
60,000		2027-03-30	No	4	A	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.50to $7.875, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range setforth above.
Includes 1,601 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 18, 2016.
The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 31, 2017.